Department of Industries, UT Administration of Dadra and Nagar Haveli and Daman and Diu
Government
Open

IPS 2022 — Vaccine Manufacturing Units Scheme (Up to ₹13 Cr) — Eligibility Criteria

Eligibility

IPS 2022 — Vaccine Manufacturing Units Scheme (Up to ₹13 Cr) is open to product · revenue-stage startups registered in India. The startup must hold MSME (Udyam) registration. The full eligibility criteria — qualifying sectors, states and entity types — are below.

Who can apply

The sub-scheme is open to vaccine manufacturing enterprises of two kinds: units starting production fresh, and existing units that commence commercial production during the operative period of IPS 2022. The Department of Industries applies the same tests to both.

  • Investment test: incentives are calculated on the Gross Fixed Capital Investment a unit makes in new buildings and in plant, machinery and equipment. Land is excluded from the calculation.
  • Expansion or diversification route: an enterprise investing in expansion or diversification qualifies where that investment exceeds 50% of its GFCI, and at least 60% of it goes into plant and machinery.
  • One activity only: during the policy period, an enterprise can claim for expansion or for diversification — not both.
  • Loan condition: the term loan must be sanctioned by a bank or financial institution in line with RBI guidelines, for an industry located inside the Union Territory. A loan sanctioned more than a year after commercial production begins disqualifies the unit from the interest subsidy.
  • Application window: the online application must reach the department within one year of the first disbursement of the loan, or by the date commercial production begins — whichever is later.
  • Cost sharing: the enterprise itself must bear at least 2% of the interest the bank levies on the term loan.
  • Ongoing duties: pollution control measures prescribed by the PCC or another competent authority must be observed; production, sales, turnover and employment details must be filed annually with the concerned District Industries Centre before the end of September; and commercial production must continue for at least five years from its start, failing which the capital investment subsidy is recovered.

IPS 2022 — Vaccine Manufacturing Units Scheme (Up to ₹13 Cr) is open to startups at the product, revenue and profitable stage working in health lifesciences. The programme is targeted at startups registered in Dadra and Nagar Haveli and Daman and Diu. Applicants should be registered as private limited, llp and opc. Applicants must hold MSME (Udyam) registration.

productrevenueprofitablehealth lifesciencesDadra and Nagar Haveli and Daman and DiuMSME required
Eligible stage
Product · Revenue
Location
Open to startups registered in India
Entity type
Private Limited, Llp, Opc, Partnership, Proprietorship
MSME registration
Required — the startup must hold MSME (Udyam) registration

← Back to IPS 2022 — Vaccine Manufacturing Units Scheme (Up to ₹13 Cr) overview